SG170823A1 - Test agent for diagnosing dyspepsia - Google Patents

Test agent for diagnosing dyspepsia

Info

Publication number
SG170823A1
SG170823A1 SG201102359-5A SG2011023595A SG170823A1 SG 170823 A1 SG170823 A1 SG 170823A1 SG 2011023595 A SG2011023595 A SG 2011023595A SG 170823 A1 SG170823 A1 SG 170823A1
Authority
SG
Singapore
Prior art keywords
measuring
gastric
present
dyspepsia
labeled
Prior art date
Application number
SG201102359-5A
Other languages
English (en)
Inventor
Makoto Inada
Jun-Ichi Kunizaki
Nobuhiro Ikei
Kuniaki Natsume
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of SG170823A1 publication Critical patent/SG170823A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/497—Physical analysis of biological material of gaseous biological material, e.g. breath
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/20—Oxygen containing
    • Y10T436/204998—Inorganic carbon compounds

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG201102359-5A 2006-04-13 2007-04-12 Test agent for diagnosing dyspepsia SG170823A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006111382 2006-04-13

Publications (1)

Publication Number Publication Date
SG170823A1 true SG170823A1 (en) 2011-05-30

Family

ID=38609531

Family Applications (1)

Application Number Title Priority Date Filing Date
SG201102359-5A SG170823A1 (en) 2006-04-13 2007-04-12 Test agent for diagnosing dyspepsia

Country Status (10)

Country Link
US (1) US20100055799A1 (ja)
EP (1) EP2011518B1 (ja)
JP (1) JP5213702B2 (ja)
KR (2) KR101504571B1 (ja)
CN (1) CN101420985B (ja)
CA (1) CA2649262A1 (ja)
ES (1) ES2488412T3 (ja)
SG (1) SG170823A1 (ja)
TW (1) TWI409091B (ja)
WO (1) WO2007119771A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2887066B1 (en) 2012-08-20 2020-08-05 Otsuka Pharmaceutical Co., Ltd. Composition for use in a method for measuring carbohydrate metabolism ability
KR20210014204A (ko) 2013-03-15 2021-02-08 오츠카 세이야쿠 가부시키가이샤 지방산 연소에 의한 인슐린 저항성의 측정 방법, 및 그에 사용하는 조성물
CN108030471B (zh) * 2017-12-20 2023-12-26 天津医科大学总医院 动物胃肠动力检测系统及检测方法
CN110743021A (zh) * 2019-11-29 2020-02-04 王相成 一种胃食管反流的液体试餐及其显像方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4830010A (en) * 1986-04-04 1989-05-16 Marshall Barry J Methods for the diagnosis of gastrointestinal disorders
US5233997A (en) * 1991-04-04 1993-08-10 Baylor College Of Medicine Non-invasive measure of intestinal transit time and uses thereof
SE504902C2 (sv) * 1994-11-02 1997-05-26 Diabact Ab Beredning för påvisande av Helicobacter pylori i magsäcken
US5707602A (en) * 1996-03-25 1998-01-13 Meretek Diagnostics Measurement of gastric emptying
US8071128B2 (en) * 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
PT860170E (pt) * 1996-08-13 2000-06-30 Kyowa Hakko Kogyo Kk Comprimidos a base de ureia marcada com isotopos
US6186958B1 (en) * 1997-02-26 2001-02-13 Oridion Medical Breath test analyzer
CA2250485C (en) * 1997-10-21 2008-04-29 Tokyo Gas Co., Ltd. Diagnostic agent for diabetes
AR019935A1 (es) * 1998-07-28 2002-03-27 Takeda Pharmaceutical Preparacion solida de desintegracion rapida, uso de una hidroxipropil celulosa poco sustituida en dicha preparacion y metodo para mejorar la capacidad dedesintegracion rapida de la misma
US6740305B1 (en) * 1999-04-09 2004-05-25 Xanthus Life Scienes, Inc. Assessment of gastric emptying disorders
KR100360827B1 (ko) * 1999-08-14 2002-11-18 주식회사 삼양사 난용성 약물을 가용화하기 위한 고분자 조성물 및 그의 제조방법
KR20030007567A (ko) * 2000-05-02 2003-01-23 오츠카 세이야쿠 가부시키가이샤 위 배설 능력 측정용 제제
US6797256B2 (en) * 2001-03-13 2004-09-28 Otsuka Pharmaceutical Co. Ltd. Composition for determining pyrimidine metabolizing activity
US7488466B2 (en) * 2001-03-13 2009-02-10 Otsuka Pharmaceutical Co., Ltd. Preparation for determining pyrimidine metabolic capacity
RU2429883C2 (ru) 2005-07-25 2011-09-27 Оцука Фармасьютикал Ко., Лтд. Композиция для перорального приема, эффективная в оценке способности метаболизировать пиридин

Also Published As

Publication number Publication date
WO2007119771A1 (ja) 2007-10-25
EP2011518A1 (en) 2009-01-07
JP5213702B2 (ja) 2013-06-19
ES2488412T3 (es) 2014-08-27
CA2649262A1 (en) 2007-10-25
CN101420985B (zh) 2011-11-09
KR20140099331A (ko) 2014-08-11
TWI409091B (zh) 2013-09-21
EP2011518A4 (en) 2011-04-20
KR20080112328A (ko) 2008-12-24
EP2011518B1 (en) 2014-06-18
KR101504571B1 (ko) 2015-03-20
CN101420985A (zh) 2009-04-29
US20100055799A1 (en) 2010-03-04
JPWO2007119771A1 (ja) 2009-08-27
TW200744701A (en) 2007-12-16
KR101440980B1 (ko) 2014-09-17

Similar Documents

Publication Publication Date Title
Dries et al. Inhalation injury: epidemiology, pathology, treatment strategies
AU2012262534B2 (en) Method of determining vasoreactivity using inhaled nitric oxide
WO2004063387A3 (en) Fluorescent silica-based nanoparticles
WO2007019376A3 (en) Methods and compositions for diagnosis of iga-and igm-mediated kidney diseases
WO2007149985A3 (en) Assessing dementia and dementia-type disorders
EP2073706A4 (en) TISSUE PERFUSION ANALYSIS SYSTEM BASED ON THE USE OF INDOCYANINE GREEN CONCENTRATION IN BLOOD
WO2006116469A3 (en) Method and apparatus for diagnosing respiratory disorders and determining the degree of exacerbations
WO2007066115A3 (en) Novel imaging agents for fibrosis
DE60204336D1 (de) Atemfunktionsanalyse mittels kapnographie
NO20083104L (no) Fast preparat
TR200101673A2 (tr) Düz kas hücrelerinin sıkışmasıyla ilgili hastalıkların tedavisindeki kompozisyonlar için biyokimyasal maddeler.
Lee et al. Malondialdehyde and 3-nitrotyrosine in exhaled breath condensate in retired elderly coal miners with chronic obstructive pulmonary disease
TW200716759A (en) Method and composition to evaluate cytochrome P450 2D6 isoenzyme activity using a breath test
Tangerman et al. Halitosis and Helicobacter pylori infection
SG170823A1 (en) Test agent for diagnosing dyspepsia
NO20092248L (no) Ny forbindelse med affinitet for amyloid
MX2009006560A (es) Un metodo mediante una prueba de aliento para la deteccion de microorganismos patogenos.
WO2009016231A3 (en) Compositions and methods for detecting histamine related disorders
EP1707219A3 (en) Radioactive kits for a gastric emptying measurement
US6626844B1 (en) Method and composition for inhibition of nitric oxide production in the oral cavity
EP3009838A1 (en) A breath test for the diagnosis of helicobacter pylori infection
WO2007070827A3 (en) Contrast agents for myocardium perfusion imaging
MX2007014803A (es) Composiciones que penetran el nucleo celular.
SE0200932D0 (sv) Diagnosis marker
Li et al. Reliability and validity of Chinese Version of Alzheimer's Disease Assessment Scale-Cognitive Part.